Bioalpha in vaccine distribution MoU


BurIn a filing with Bursa Malaysia, it said the contract was effective since Jan 22, and subject to approval from the relevant authorities for the distribution and sale of the vaccine.

KUALA LUMPUR: Bioalpha Holdings Bhd’s subsidiary has entered a memorandum of understanding (MoU) with Zuellig Pharma Sdn Bhd for the import and distribution of the Covid-19 vaccine in Malaysia.

In a filing with Bursa Malaysia, it said the contract was effective since Jan 22, and subject to approval from the relevant authorities for the distribution and sale of the vaccine.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Bioalpha , vaccine , distribution , Zuellig Pharma ,

Next In Business News

SimeProp strengthens Johor presence
RCE Capital earnings to pick up after weaker 1Q27
Pioneer Heat eyes RM21.68mil IPO
MSC quarterly bottom line surges on higher tin prices�
Sersol waiting for green light to diversify business
NXP doubles down on regional footprint with factory expansion
RE players need more flexible risk assessment
Energy transition sparks new investment themes
EITA secures LRT project worth RM62mil
SSBB clinches RM105mil data centre contract

Others Also Read